Harbin Pharmaceutical Group Co., Ltd. GENERAL Pharm. FACTORY
-
Founded in:
1994-05-19 -
Country:
China -
Address:
No. 388, Hahei Highway, Hulan District (production base No. 109, Xuefu Road, Nangang District, No. 1, Junmin Street, Xiangfang District) -
Tax NO.:
912301008280277137 -
Registered Funds:
- -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Magnesium trisilicate |
This product can neutralize gastric acid and protect the gastric mucosa with a long-lasting effect.
More
This product can neutralize gastric acid and protect the gastric mucosa with a long-lasting effect. |
0.0125g | 14987-04-3 | 11 |
| Aluminum hydroxide |
This product can neutralize gastric acid and protect the gastric mucosa with a long-lasting effect.
More
This product can neutralize gastric acid and protect the gastric mucosa with a long-lasting effect. |
0.05g | 21645-51-2 | 14 |
| Alginic acid |
This product can neutralize gastric acid and protect the gastric mucosa with a long-lasting effect.
More
This product can neutralize gastric acid and protect the gastric mucosa with a long-lasting effect. |
0.25g | 9005-32-7 | 4 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Oxytetracycline |
This product is an antibiotic with broad-spectrum antibacterial effect and is suitable for skin inflammation caused by Gram-positive or Gram-positive bacteria.
More
This product is an antibiotic with broad-spectrum antibacterial effect and is suitable for skin inflammation caused by Gram-positive or Gram-positive bacteria. |
79-57-2 | 34 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Gemfibrozil |
This product is a lipid-regulating drug of the clofibric acid derivative class. Its mechanism of action in lowering blood lipids is not yet fully understood. It may involve peripheral fat decomposition, reduce the liver's uptake of free fatty acids and reduce the formation of triglycerides in the liver, inhibit the synthesis of very low-density lipoprotein apolipoproteins and reduce the production of very low-density lipoproteins. This product reduces blood triglycerides and increases blood high-density lipoprotein concentrations. Although it can slightly reduce blood low-density lipoprotein cholesterol blood concentrations, it may increase low-density lipoprotein in type IV hyperlipoproteinemia. A 5-year placebo-controlled study showed that this product can reduce the occurrence of severe coronary heart disease sudden death and myocardial infarction. Long-term administration of 10 times the human dose to rats increased the incidence of liver malignancies and benign testicular tumors.
More
This product is a lipid-regulating drug of the clofibric acid derivative class. Its mechanism of action in lowering blood lipids is not yet fully understood. It may involve peripheral fat decomposition, reduce the liver's uptake of free fatty acids and reduce the formation of triglycerides in the liver, inhibit the synthesis of very low-density lipoprotein apolipoproteins and reduce the production of very low-density lipoproteins. This product reduces blood triglycerides and increases blood high-density lipoprotein concentrations. Although it can slightly reduce blood low-density lipoprotein cholesterol blood concentrations, it may increase low-density lipoprotein in type IV hyperlipoproteinemia. A 5-year placebo-controlled study showed that this product can reduce the occurrence of severe coronary heart disease sudden death and myocardial infarction. Long-term administration of 10 times the human dose to rats increased the incidence of liver malignancies and benign testicular tumors. |
25812-30-0 | 14 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Levofloxacin Hydrochloride |
This product is the levorotatory form of ofloxacin, and its antibacterial activity is about twice that of ofloxacin. Its main mechanism of action is to inhibit the activity of bacterial DNA gyrase (bacterial topoisomerase II) and hinder bacterial DNA replication. It has good antibacterial effects on most Enterobacteriaceae, Pseudomonas aeruginosa, Haemophilus influenzae, gonococci and other Gram-negative bacteria, as well as some methicillin-sensitive Staphylococci, Streptococcus pneumoniae, Streptococcus pyogenes, hemolytic Streptococcus and other Gram-positive bacteria, Legionella, Mycoplasma, Chlamydia, but has poor effects on anaerobic bacteria and enterococci.
More
This product is the levorotatory form of ofloxacin, and its antibacterial activity is about twice that of ofloxacin. Its main mechanism of action is to inhibit the activity of bacterial DNA gyrase (bacterial topoisomerase II) and hinder bacterial DNA replication. It has good antibacterial effects on most Enterobacteriaceae, Pseudomonas aeruginosa, Haemophilus influenzae, gonococci and other Gram-negative bacteria, as well as some methicillin-sensitive Staphylococci, Streptococcus pneumoniae, Streptococcus pyogenes, hemolytic Streptococcus and other Gram-positive bacteria, Legionella, Mycoplasma, Chlamydia, but has poor effects on anaerobic bacteria and enterococci. |
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| D-CAMPHOR |
Promote local skin blood circulation, relieve pain and itching
More
Promote local skin blood circulation, relieve pain and itching |
30mg | 464-49-3 | 2 |
| Orthoboric acid |
Mild antibacterial and anti-inflammatory effects
More
Mild antibacterial and anti-inflammatory effects |
50mg | 10043-35-3 | 18 |
| Glycerol |
The camphor contained in this product can promote local skin blood circulation and relieve pain and itching. The boric acid contained in this product has mild antibacterial and anti-inflammatory effects.
More
The camphor contained in this product can promote local skin blood circulation and relieve pain and itching. The boric acid contained in this product has mild antibacterial and anti-inflammatory effects. |
50mg | 56-81-5 | 62 |